Urinary Biomarkers to Detect Early-Stage Renal Disease Progression in Diabetic Individuals Without Concurrent Hypertension: A 30-Month Observational Study
Diabetes Technology and Obesity Medicine · 2025
DOI: 10.1089/dtom.2024.0008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Technology and Obesity Medicine, 2025. Verfasst von Himansu Sekhar Mahapatra und 3 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Background: Diabetic nephropathy (DN) is traditionally diagnosed based on urinary albumin-to-creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR). Newer biomarkers, such as urinary cystatin C, neutrophil gelatinase-associated lipocalin (NGAL), interleukin (IL)-18, and angiotensinogen, may offer better prediction of renal dysfunction in diabetes without hypertension.
Zitieren
APA
Mahapatra, H. S., Binoy, R., Kulshreshtha, B., & Chitkara, A. (2025). Urinary Biomarkers to Detect Early-Stage Renal Disease Progression in Diabetic Individuals Without Concurrent Hypertension: A 30-Month Observational Study. Diabetes Technology and Obesity Medicine. https://doi.org/10.1089/dtom.2024.0008
Vancouver
Mahapatra HS, Binoy R, Kulshreshtha B, Chitkara A. Urinary Biomarkers to Detect Early-Stage Renal Disease Progression in Diabetic Individuals Without Concurrent Hypertension: A 30-Month Observational Study. Diabetes Technology and Obesity Medicine. 2025. doi:10.1089/dtom.2024.0008
BibTeX
@article{Mahapatra2025,
author = {Mahapatra, Himansu Sekhar and Binoy, Renju and Kulshreshtha, Bindu and Chitkara, Anubhuti},
title = {Urinary Biomarkers to Detect Early-Stage Renal Disease Progression in Diabetic Individuals Without Concurrent Hypertension: A 30-Month Observational Study},
journal = {Diabetes Technology and Obesity Medicine},
year = {2025},
doi = {10.1089/dtom.2024.0008}
}
EUVIMED